Gastro Flashcards
What is Zollinger-Ellison syndrome?
Zollinger-Ellison syndrome is a condition characterised by excessive levels of gastrin secondary to a gastrin-secreting tumour.
. What is Zollinger-Ellison Syndrome?
Zollinger-Ellison Syndrome (ZES) is a rare condition caused by a gastrin-secreting tumor (gastrinoma), leading to excess stomach acid production and severe peptic ulcers.
๐ Location of Gastrinoma:
Pancreas (most common)
Duodenum
Lymph nodes
๐ฌ Association with MEN1 Syndrome:
25% of ZES cases are linked to Multiple Endocrine Neoplasia type 1 (MEN1)
MEN1 involves parathyroid, pituitary, and pancreatic tumors
- Pathophysiology
1๏ธโฃ Gastrinoma secretes excess gastrin โ Stimulates parietal cells โ Increased HCl (acid) production
2๏ธโฃ Severe acid hypersecretion โ Multiple, recurrent peptic ulcers (often resistant to treatment)
3๏ธโฃ Acid inactivates pancreatic enzymes โ Malabsorption & diarrhea
Where are most of the tumors found in Zollinger-Ellison syndrome?
The majority of these tumours are found in the first part of the duodenum, with the second most common location being the pancreas.
What are the features of Zollinger-Ellison syndrome?
multiple gastroduodenal ulcers
diarrhoea
malabsorption
What are the most common glands affected in MEN1?
The most common glands affected are the parathyroids, pancreas, and pituitary.
What types of drugs cause drug-induced cholestasis?
oral contraceptive pill
Which drugs are known to cause a hepatocellular picture with a rise in alanine transaminase (ALT) to greater than two times the upper limit of normal?
Amiodarone
Methyldopa
Nitrofurantoin
Phenytoin
What is the management of First episode of C. difficile infection?
first-line therapy is oral vancomycin for 10 days
second-line therapy: oral fidaxomicin
third-line therapy: oral vancomycin +/- IV metronidazole
What is the management of recurrent infections of C. difficile infection?
recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode
within 12 weeks of symptom resolution: oral fidaxomicin
after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin
What is the management of Life-threatening C. difficile infection?
oral vancomycin AND IV metronidazole
specialist advice - surgery may be considered
What on LFTS suggests alcoholic liver disease?
the ratio of AST:ALT is normally > 2, a ratio of > 3 is strongly suggestive of acute alcoholic hepatitis
What is the pathophysiology of pernicious anaemia?
antibodies to intrinsic factor +/- gastric parietal cells
intrinsic factor antibodies โ bind to intrinsic factor blocking the vitamin B12 binding site
gastric parietal cell antibodies โ reduced acid production and atrophic gastritis. Reduced intrinsic factor production โ reduced vitamin B12 absorption
vitamin B12 is important in both the production of blood cells and the myelination of nerves โ megaloblastic anaemia and neuropathy
What is perncious anaemia?
Pernicious anaemia is an autoimmune disorder affecting the gastric mucosa that results in vitamin B12 deficiency.
What are the causes of perncious anaemia?
Whilst pernicious anaemia is the most common cause of vitamin B12 deficiency, itโs not the only cause. Other causes include atrophic gastritis (e.g. secondary to H. pylori infection), gastrectomy, malnutrition (e.g. alcoholism).
What are the risk factors of pernicious anaemia?
more common in females (F:M = 1.6:1) and typically develops in middle to old age
associated with other autoimmune disorders: thyroid disease, type 1 diabetes mellitus, Addisonโs, rheumatoid and vitiligo
more common if blood group A
What are the features of pernicious anaemia?
anaemia features
lethargy
pallor
dyspnoea
neurological features
peripheral neuropathy: โpins and needlesโ, numbness. Typically symmetrical and affects the legs more than the arms
subacute combined degeneration of the spinal cord: progressive weakness, ataxia and paresthesias that may progress to spasticity and paraplegia
neuropsychiatric features: memory loss, poor concentration, confusion, depression, irritabiltiy
other features
mild jaundice: combined with pallor results in a โlemon tingeโ
atrophic glossitis โ sore tongue
What major disease is pernicious anaemia associated with?
increased risk of gastric cancer
What is the treatment for achalasia?
pneumatic (balloon) dilation is increasingly the preferred first-line option
less invasive and quicker recovery time than surgery
patients should be a low surgical risk as surgery may be required if complications occur
surgical intervention with a Heller cardiomyotomy should be considered if recurrent or persistent symptoms
intra-sphincteric injection of botulinum toxin is sometimes used in patients who are a high surgical risk
drug therapy (e.g. nitrates, calcium channel blockers) has a role but is limited by side-effectsHeller cardiomyotomy
What are the adverse effects of PPIs?
hyponatraemia, hypomagnasaemia
osteoporosis โ increased risk of fractures
microscopic colitis
increased risk of C. difficile infections
What are the early symptoms of Haemochromatosis?
early symptoms include fatigue, erectile dysfunction and arthralgia (often of the hands)
Which features of haemochromatosis is reversible with treatment?
which features are reversible with treatment:
Reversible complications
Cardiomyopathy
Skin pigmentation
Irreversible complications
Liver cirrhosis**
Diabetes mellitus
Hypogonadotrophic hypogonadism
Arthropathy
What is the management of Small bowel bacterial overgrowth syndrome (SBBOS)?
correction of the underlying disorder
antibiotic therapy:rifaximin is now the treatment of choice due to relatively low resistance. Co-amoxiclav or metronidazole are also effective in the majority of patients.
How to diagnose Small bowel bacterial overgrowth syndrome (SBBOS)?
hydrogen breath test
small bowel aspiration and culture: this is used less often as invasive and results are often difficult to reproduce
clinicians may sometimes give a course of antibiotics as a diagnostic trial
What are the risk factors for Small bowel bacterial overgrowth syndrome (SBBOS)?
neonates with congenital gastrointestinal abnormalities
scleroderma
diabetes mellitus
How to treat recurrent infection of C. difficile?
recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode
within 12 weeks of symptom resolution: oral fidaxomicin
after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin